Probe Manufacturing to Exhibit at the MedTech World Medical Device & Manufacturing Conference
Irvine, California, (February 11, 2014) Probe Manufacturing, Inc., (OTC QB: CETY) (“Probe” or “the Company”), a global electronics design & manufacturing services company, to exhibit at the MedTech World Medical Device & Manufacturing Conference on February 11-13, 2014 at the Anaheim Convention Center in Anaheim, California.
The MedTech World Medical Device & Manufacturing Conference is the nation’s most comprehensive and largest medical device event with over 2,000 exhibiting suppliers and manufacturers. The conference gathers MedTech leaders and practitioners, sharing best practices and innovative ways to transform the future of medical devices. The conference offers a networking platform bringing together leading manufacturers, product experts and process improvers for solutions and industry knowledge on new technology, new materials, quality control, design and advanced manufacturing techniques.
Kam Mahdi, CEO of Probe manufacturing, added, “The MedTech World Conference is the perfect venue for Probe Manufacturing to continue to broaden the reach of our electronic manufacturing services. We have developed an expertise in the medical industry to streamline the manufacturing process for mid-tier firms from concept to fulfillment. We look forward to continuing to build our presence within the medical device manufacturing industry.”
For more information please visit http://www.canontradeshows.com/expo/west14/index.html.
About Probe Manufacturing
Probe Manufacturing is a Global Electronics Design & Manufacturing Services Company providing Original Equipment Manufacturers with electronics manufacturing services through its domestic factories in the United States. Headquartered in Irvine, California, Probe has been serving industrial, instrumentation, medical, aerospace, defense, alternative energy, and telecommunication industries since 1994. Probe’s common stock is traded on the OTC Market QB under the symbol CETY. Further information is available on Probe’s website: www.ceti.io.
This release contains certain forward-looking statements (under Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended) with respect to whether Probe’s ability to broaden the reach of our electronic manufacturing services within the medical device manufacturing industry or to build or enhance our presence within the medical device manufacturing industry. Because such statements include risks, uncertainties and contingencies, actual results may differ materially from those expressed or implied by such forward-looking statements. These risks, uncertainties and contingencies include, but are not limited to, the following: uncertainties relating to changes in general economic and market conditions; uncertainties regarding changes in the EMS industry; the uncertainties relating to the implementation of our global business strategy; and other risk factors as outlined in the company’s periodic reports, as filed with the U.S. Securities and Exchange Commission. Forward-looking statements in this document speak only as of the date on which such statements were made, and we undertake no obligation to update any such statements that may become untrue because of subsequent events. We claim the safe harbor protection for forward-looking statements contained in the Private Securities Litigation Reform Act of 1995.
Company Contact:
Probe Manufacturing, Inc.
Kam Mahdi, Chairman and CEO
949-273-4990 X814
or
John Bennett, CFO
949-273-4990 X807
Investor Contact:
Alliance Advisors, LLC
Alan Sheinwald
(914) 669-0222
or
Valter Pinto
(914) 669-0222 x201